386 related articles for article (PubMed ID: 17014576)
1. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study.
Yuen MF; Tam S; Fung J; Wong DK; Wong BC; Lai CL
Aliment Pharmacol Ther; 2006 Oct; 24(8):1179-86. PubMed ID: 17014576
[TBL] [Abstract][Full Text] [Related]
2. [Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B].
Wang SL; Yao NL; Lv WL
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2468-70. PubMed ID: 18330233
[TBL] [Abstract][Full Text] [Related]
3. A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients.
Wong VW; Law MY; Hui AY; Lo AO; Li CY; Soo MT; Leung HY; Chan HL
Complement Ther Med; 2005 Sep; 13(3):175-82. PubMed ID: 16150371
[TBL] [Abstract][Full Text] [Related]
4. Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan.
Chen FP; Kung YY; Chen YC; Jong MS; Chen TJ; Chen FJ; Hwang SJ
J Ethnopharmacol; 2008 Apr; 117(1):84-91. PubMed ID: 18321671
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Kang Gang Qian Granule (KGQG) on clinical and pathological features in chronic hepatitis B patients].
Xiao HJ; Shi CG; Zhang AP; Li P; Fan ZS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):369-71. PubMed ID: 18322606
[TBL] [Abstract][Full Text] [Related]
6. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
Yang HZ; Wang FL; Wang YZ; Shen WS; Xu GL; Yang YW; Huang XL
Zhong Yao Cai; 2006 Jul; 29(7):748-52. PubMed ID: 17059015
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of Fufang Biejia Ruangan tablet in patients with chronic hepatitis B complicated with hepatic fibrosis].
Chen JM; Yang YP; Chen DY; Han J; Jin XY; Huang ZX; Xu CB; Shen YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):358-60. PubMed ID: 18322602
[TBL] [Abstract][Full Text] [Related]
8. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial with traditional Chinese medicine intervention ''tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment'' for chronic hepatitis B-associated liver failure.
Li HM; Ye ZH; Zhang J; Gao X; Chen YM; Yao X; Gu JX; Zhan L; Ji Y; Xu JL; Zeng YH; Yang F; Xiao L; Sheng GG; Xin W; Long Q; Zhu QJ; Shi ZH; Ruan LG; Yang JY; Li CC; Wu HB; Chen SD; Luo XL
World J Gastroenterol; 2014 Dec; 20(48):18458-65. PubMed ID: 25561817
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
Schiff E; Simsek H; Lee WM; Chao YC; Sette H; Janssen HL; Han SH; Goodman Z; Yang J; Brett-Smith H; Tamez R
Am J Gastroenterol; 2008 Nov; 103(11):2776-83. PubMed ID: 18721244
[TBL] [Abstract][Full Text] [Related]
11. [Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
Huang JS; Luo X; Yu JX; Liu W; Chen XW; Xie L; Zhu XY; Chen GY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):408-11. PubMed ID: 17631708
[TBL] [Abstract][Full Text] [Related]
12. [The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis].
Ma H; Guo F; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1832-5. PubMed ID: 17922993
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis.
Ma H; Wei L; Guo F; Zhu S; Sun Y; Wang H
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1250-8. PubMed ID: 18624896
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients.
Akbar N; Tahir RA; Santoso WD; Soemarno ; Sumaryono ; Noer HM; Liu G
Chin Med J (Engl); 1998 Mar; 111(3):248-51. PubMed ID: 10374427
[TBL] [Abstract][Full Text] [Related]
15. Chinese herbal medicine for cancer pain.
Xu L; Lao LX; Ge A; Yu S; Li J; Mansky PJ
Integr Cancer Ther; 2007 Sep; 6(3):208-34. PubMed ID: 17761635
[TBL] [Abstract][Full Text] [Related]
16. Serious cutaneous adverse reactions to traditional Chinese medicines.
Lim YL; Thirumoorthy T
Singapore Med J; 2005 Dec; 46(12):714-7. PubMed ID: 16308646
[TBL] [Abstract][Full Text] [Related]
17. The effects of a Chinese medicinal suppository (Vitalliver) on insulin-like growth factor 1 and homocysteine in patients with hepatitis B infection.
Chui SH; Chan K; Chui AK; Shek LS; Wong RN
Phytother Res; 2005 Aug; 19(8):674-8. PubMed ID: 16177969
[TBL] [Abstract][Full Text] [Related]
18. [Research on medical speciality of traditional Chinese medicines using dot-immunoblotting method based on polyclonal antibody prepared from traditional Chinese medicines with hot/cold nature].
Wang H; Dou Y; Tian J; Li F; Wang S; Wang Z
Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(4):438-42. PubMed ID: 19459307
[TBL] [Abstract][Full Text] [Related]
19. [Evaluate of the therapeutic efficiency of the Chinese traditional medicine Gansu granule on chronic hepatitis B].
Chen XR; Yao H; Jiang Y; Wu SM; Zhu XF; Zhou XQ; Cai YM; Zhuo YH; Chen JJ; Wang LT
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):50. PubMed ID: 14761289
[No Abstract] [Full Text] [Related]
20. [Therapeutic efficacy of Chinese traditional medicine in the treatment of fulminate hepatitis].
Gao JR
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):635. PubMed ID: 15504305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
